
Zuvactum 4gm/0.5gm Injection
Marketer
LeeMed Pharmaceuticals
Salt Composition
Piperacillin (4gm) + Tazobactum (0.5gm)
Overview Zuvactum 4gm/0.5gm Injection
Combiflox 4gm/0.5gm injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, the dosage and frequency are determined by a physician based on individual health status. Strict adherence to prescribed usage is crucial. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Pre-treatment disclosure of antibiotic allergies, kidney, or liver conditions is essential; adjustments to dosage or alternative medication may be necessary. Under medical guidance, this medication is generally considered safe during pregnancy and lactation.
Uses of Zuvactum 4gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Zuvactum 4gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Zuvactum 4gm/0.5gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Zuvactum 4gm/0.5gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is discouraged.
How Zuvactum 4gm/0.5gm Injection works:
Zuvactum 4gm/0.5gm Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Zuvactum 4gm/0.5gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Zuvactum (4gm/0.5gm) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Zuvactum (4gm/0.5gm) poses no known breastfeeding safety concerns. Research in humans indicates negligible transfer to breast milk, rendering it unlikely to adversely affect the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Zuvactum 4gm/0.5gm Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Zuvactum 4gm/0.5gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Zuvactum 4gm/0.5gm Injection in patients with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Zuvactum 4gm/0.5gm Injection :
Omit doses of Zuvactum 4gm/0.5gm Injection only after contacting your physician.
Facts to Know About Zuvactum 4gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
